ペプチドリームの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/11/15 | 2,830 | 2,986 | 2,828 | 2,931 | +101 | +3.6% | 2,133,200 |
| 2021/11/12 | 2,674 | 2,839 | 2,668 | 2,830 | +306 | +12.1% | 3,041,100 |
| 2021/11/11 | 2,510 | 2,562 | 2,487 | 2,524 | -17 | -0.7% | 1,011,700 |
| 2021/11/10 | 2,550 | 2,599 | 2,516 | 2,541 | -29 | -1.1% | 1,042,000 |
| 2021/11/09 | 2,685 | 2,689 | 2,561 | 2,570 | -90 | -3.4% | 1,268,700 |
| 2021/11/08 | 2,800 | 2,812 | 2,626 | 2,660 | -180 | -6.3% | 1,535,200 |
| 2021/11/05 | 2,800 | 2,846 | 2,756 | 2,840 | +56 | +2% | 1,183,400 |
| 2021/11/04 | 2,803 | 2,825 | 2,678 | 2,784 | +1 | ±0% | 1,504,600 |
| 2021/11/02 | 2,800 | 2,894 | 2,775 | 2,783 | -16 | -0.6% | 1,621,100 |
| 2021/11/01 | 2,765 | 2,839 | 2,762 | 2,799 | +46 | +1.7% | 1,140,900 |
| 2021/10/29 | 2,727 | 2,767 | 2,682 | 2,753 | -12 | -0.4% | 1,192,000 |
| 2021/10/28 | 2,655 | 2,830 | 2,650 | 2,765 | +111 | +4.2% | 1,922,300 |
| 2021/10/27 | 2,714 | 2,732 | 2,599 | 2,654 | -100 | -3.6% | 2,000,200 |
| 2021/10/26 | 2,519 | 2,796 | 2,473 | 2,754 | +250 | +10% | 4,147,200 |
| 2021/10/25 | 2,496 | 2,540 | 2,445 | 2,504 | -45 | -1.8% | 1,640,300 |
| 2021/10/22 | 2,571 | 2,595 | 2,546 | 2,549 | -41 | -1.6% | 1,526,800 |
| 2021/10/21 | 2,696 | 2,696 | 2,583 | 2,590 | -151 | -5.5% | 1,924,100 |
| 2021/10/20 | 2,733 | 2,776 | 2,710 | 2,741 | +29 | +1.1% | 1,160,600 |
| 2021/10/19 | 2,629 | 2,747 | 2,627 | 2,712 | +99 | +3.8% | 1,897,000 |
| 2021/10/18 | 2,712 | 2,736 | 2,603 | 2,613 | -98 | -3.6% | 1,690,900 |
| 2021/10/15 | 2,668 | 2,723 | 2,512 | 2,711 | +67 | +2.5% | 3,193,700 |
| 2021/10/14 | 2,727 | 2,757 | 2,638 | 2,644 | -64 | -2.4% | 2,289,000 |
| 2021/10/13 | 2,740 | 2,804 | 2,702 | 2,708 | +8 | +0.3% | 1,892,600 |
| 2021/10/12 | 2,826 | 2,852 | 2,612 | 2,700 | -169 | -5.9% | 3,957,300 |
| 2021/10/11 | 2,998 | 3,005 | 2,863 | 2,869 | -114 | -3.8% | 1,767,600 |
| 2021/10/08 | 3,030 | 3,085 | 2,971 | 2,983 | +34 | +1.2% | 1,166,700 |
| 2021/10/07 | 2,933 | 3,040 | 2,893 | 2,949 | +8 | +0.3% | 1,753,500 |
| 2021/10/06 | 3,180 | 3,215 | 2,936 | 2,941 | -219 | -6.9% | 2,318,800 |
| 2021/10/05 | 3,295 | 3,330 | 3,160 | 3,160 | -225 | -6.6% | 1,361,100 |
| 2021/10/04 | 3,605 | 3,615 | 3,375 | 3,385 | -170 | -4.8% | 986,200 |
| 2021/10/01 | 3,600 | 3,610 | 3,520 | 3,555 | -85 | -2.3% | 620,700 |
| 2021/09/30 | 3,695 | 3,790 | 3,630 | 3,640 | -55 | -1.5% | 720,500 |
| 2021/09/29 | 3,695 | 3,700 | 3,595 | 3,695 | -70 | -1.9% | 647,400 |
| 2021/09/28 | 3,780 | 3,810 | 3,755 | 3,765 | ±0 | ±0% | 412,800 |
| 2021/09/27 | 3,785 | 3,805 | 3,745 | 3,765 | -35 | -0.9% | 384,600 |
| 2021/09/24 | 3,775 | 3,805 | 3,735 | 3,800 | +65 | +1.7% | 453,300 |
| 2021/09/22 | 3,840 | 3,840 | 3,730 | 3,735 | -50 | -1.3% | 517,300 |
| 2021/09/21 | 3,790 | 3,810 | 3,730 | 3,785 | -90 | -2.3% | 511,300 |
| 2021/09/17 | 3,840 | 3,875 | 3,830 | 3,875 | +45 | +1.2% | 682,600 |
| 2021/09/16 | 3,880 | 3,880 | 3,750 | 3,830 | -50 | -1.3% | 672,800 |
| 2021/09/15 | 3,915 | 3,930 | 3,850 | 3,880 | -35 | -0.9% | 442,300 |
| 2021/09/14 | 3,990 | 3,990 | 3,900 | 3,915 | -45 | -1.1% | 465,600 |
| 2021/09/13 | 3,950 | 4,005 | 3,900 | 3,960 | ±0 | ±0% | 375,700 |
| 2021/09/10 | 3,975 | 3,995 | 3,915 | 3,960 | -75 | -1.9% | 803,200 |
| 2021/09/09 | 4,015 | 4,070 | 4,005 | 4,035 | -25 | -0.6% | 372,800 |
| 2021/09/08 | 4,040 | 4,140 | 4,040 | 4,060 | +80 | +2% | 800,400 |
| 2021/09/07 | 4,015 | 4,075 | 3,955 | 3,980 | -25 | -0.6% | 561,100 |
| 2021/09/06 | 4,025 | 4,025 | 3,970 | 4,005 | +15 | +0.4% | 411,500 |
| 2021/09/03 | 4,030 | 4,050 | 3,885 | 3,990 | +25 | +0.6% | 988,300 |
| 2021/09/02 | 3,985 | 4,000 | 3,910 | 3,965 | -55 | -1.4% | 703,300 |
851～
900
件表示中 / 2910件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ペプチド | 191,600円 | +5.0% | +1.5% | 0.00% | 16.45倍 | 4.38倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 久光薬 | 436,500円 | +5.8% | +1.2% | 2.75% | 14.48倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 434,700円 | +20.9% | +87.3% | 3.13% | 9.71倍 | 1.12倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 336,300円 | +8.0% | -15.3% | 3.69% | 9.44倍 | 0.92倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 199,000円 | +4.0% | +25.4% | 2.66% | 8.70倍 | 1.14倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム
